KRISTIN FOSTER: Open Payments
NPI 1245696848 · NATCHEZ, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 65 payments from 13 companies in 2025. Trend: 2023 $604 · 2024 $843 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $572 |
| Phathom Pharmaceuticals, Inc. | 5 | $148 |
| Ardelyx, Inc. | 6 | $130 |
| Lilly USA, LLC | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Janssen Biotech, Inc. | 2 | $35 |
| GENZYME CORPORATION | 1 | $27 |
| Novo Nordisk Inc | 1 | $23 |
Products named: RINVOQ, VOQUEZNA, IBSRELA, LINZESS, DUPIXENT, CREON, OMVOH, SKYRIZI.
Industry payments across MS — which companies pay providers there.
